I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
What It Means When Dry AMD Becomes Wet – And Why Urgent Retina Care Matters
Understanding Dry and Wet AMD
AMD affects the macula, the small central portion of the retina responsible for sharp, detailed vision. The dry and wet forms of AMD behave very differently, and understanding how each works helps explain why the conversion from one to the other demands immediate attention.
Dry AMD is the most common form of macular degeneration, accounting for approximately 85 to 90 percent of all AMD cases. In dry AMD, small yellow deposits called drusen build up beneath the retina, the light-sensitive tissue lining the back of the eye. Over time, these deposits can cause the macula to thin and deteriorate, gradually affecting central vision.
Dry AMD typically progresses slowly over years. People with early-stage dry AMD often notice little or no change in their vision at first. As the condition advances, blurred central vision, difficulty reading, and trouble recognizing faces become more common. The slow pace of dry AMD is one reason why regular monitoring appointments are so important: changes can be subtle until they are not.
Wet AMD occurs when the eye responds to retinal damage by producing new, abnormal blood vessels beneath the macula. This process is known as choroidal neovascularization, which means the growth of fragile new blood vessels in the layer beneath the retina. These vessels are poorly formed and prone to leaking fluid and blood into the macula, causing it to swell and distort.
A protein called vascular endothelial growth factor, or VEGF, drives this process. VEGF signals the body to create new blood vessels, but in wet AMD, those vessels form in the wrong location and cause damage rather than healing. Without treatment, the leaking fluid, blood, and resulting scar tissue can permanently injure the macula within weeks or months.
Only about 10 to 15 percent of people with dry AMD develop the wet form. However, wet AMD is responsible for roughly 90 percent of severe vision loss caused by the disease. The conversion can happen quickly, sometimes without noticeable warning before significant damage has already occurred. Nearly 20 million Americans aged 40 and older have been diagnosed with some form of AMD, and over one million have late-stage, vision-threatening disease. This is why consistent monitoring by a retina specialist is so critical for anyone living with dry AMD, regardless of how stable things have felt.
Who Is at Risk for Conversion
Not everyone with dry AMD faces the same likelihood of developing wet AMD. Several factors, including how advanced the dry form has become, significantly shape this risk.
The risk of converting from dry to wet AMD rises as the condition advances. People with early dry AMD have a relatively low conversion rate. Those with intermediate dry AMD face a meaningfully higher risk, and advanced dry AMD carries an even greater likelihood of conversion. Overall, the estimated risk of progressing from dry to wet AMD is roughly 1 to 4.7 percent within one year and 13 to 18 percent within three years, depending on disease stage. Advanced dry AMD with geographic atrophy, areas where retinal cells have permanently died, can raise this risk further, as the existing damage may trigger abnormal blood vessel growth.
Patients who already have wet AMD in one eye face a significantly higher risk of developing it in the other. Research shows this risk is approximately five to six times higher compared to patients who have dry AMD in both eyes. For this reason, monitoring the unaffected eye is just as important as treating the one already receiving care, and it is a routine part of every evaluation we perform.
Several other characteristics are associated with a higher likelihood of conversion from dry to wet AMD.
- Age, particularly after 60, is the single most significant risk factor
- Female sex is associated with a somewhat higher rate of conversion
- White race and Northern European ancestry are linked to higher overall AMD risk
- Smoking damages retinal blood vessels and accelerates changes in the macula
- Family history of AMD increases risk across the board
While some of these factors are outside your control, choices such as quitting smoking, maintaining a healthy diet, and keeping all scheduled monitoring appointments can make a real difference in protecting your vision over time.
Warning Signs of Wet AMD
Wet AMD can develop rapidly, and recognizing its early symptoms is essential. If you notice any of the following changes, do not wait for your next scheduled appointment. Contact a retina specialist right away.
One of the earliest and most distinctive signs of wet AMD is seeing straight lines as wavy, bent, or curved. Door frames, telephone poles, floor tiles, or rows of printed text may suddenly appear to bow or lean. This distortion occurs because leaked fluid causes the macula to swell, warping the layer of cells that normally process visual detail into clean, sharp images. This symptom often starts in one eye and can worsen rapidly over the course of days.
New dark, gray, or blank areas appearing in the center of your visual field can be a sign that wet AMD has developed. These spots may start small but can enlarge quickly without treatment. You might notice what looks like a smudge or shadow when looking directly at someone or something, while your peripheral vision remains intact. Colors may also appear washed out or less vivid in the affected eye.
A noticeable or sudden decrease in how clearly you see, especially in one eye, can indicate that conversion has occurred. Reading, driving, or recognizing faces may become harder over a very short period. Any rapid change in visual clarity should be treated as urgent. Do not wait to see if symptoms improve on their own, because with wet AMD, they typically will not without treatment.
An Amsler grid is a simple testing tool that resembles graph paper with a small dot at the center. By covering one eye and looking directly at the dot, you can check for subtle changes in your central vision. If the surrounding lines appear wavy, broken, blurry, or missing, it may indicate that fluid has accumulated beneath the macula. Retina specialists recommend that patients with dry AMD check an Amsler grid daily with each eye separately. Any new or worsening change should prompt an immediate call to a retina specialist rather than waiting for the next scheduled visit.
How Wet AMD Is Diagnosed
If conversion to wet AMD is suspected, a retina specialist will use a combination of careful clinical examination and advanced imaging to confirm the diagnosis and plan the most effective treatment approach.
A comprehensive dilated eye exam is always part of the evaluation. Dilating drops widen the pupil so the specialist can examine the retina and macula in detail using specialized lenses and a slit lamp. During this exam, the specialist looks for signs of fluid, blood, or abnormal blood vessel activity beneath the retinal surface. This hands-on examination provides clinical detail that imaging alone cannot fully capture.
Optical coherence tomography, or OCT, is a noninvasive imaging test that produces highly detailed cross-sectional pictures of the retinal layers. It can detect even very small amounts of fluid or swelling within or beneath the retina. OCT is one of the most important tools for identifying the transition from dry to wet AMD and for tracking the retina's response to treatment over time. The test takes only a few minutes, requires no injected dye, and is performed at every monitoring and follow-up visit.
In fluorescein angiography, a special dye is injected into a vein in the arm. As the dye travels through the blood vessels of the retina, a camera takes rapid photographs to capture the flow. Leaking or abnormal vessels show up clearly in these images. This test helps the retina specialist identify the exact location, size, and type of abnormal blood vessel activity, which is especially important for planning treatment and confirming the diagnosis of wet AMD.
OCT angiography, or OCTA, is a newer imaging technique that maps blood flow within the retina without the need for injected dye. It can identify abnormal vessel networks and early signs of choroidal neovascularization. While OCTA does not fully replace fluorescein angiography in all clinical situations, it offers a quick and comfortable option for monitoring patients at risk for conversion or those already in treatment.
Treatment Options for Wet AMD
Treatment for wet AMD has improved substantially over the past two decades, and early intervention gives patients the best chance of preserving central vision. All treatment decisions are guided by a retina specialist based on each individual's imaging findings, disease characteristics, and overall health.
The primary treatment for wet AMD is intravitreal anti-VEGF therapy, which involves injecting medication directly into the eye to block the VEGF protein that drives abnormal blood vessel growth and leakage. By suppressing VEGF activity, these injections can slow or stop further damage to the macula. In many cases, they may also help stabilize or partially restore vision that has already been affected. Anti-VEGF therapy has dramatically improved outcomes for wet AMD compared to the era before these treatments existed.
Several anti-VEGF medications are currently FDA-approved for wet AMD. A retina specialist will recommend the most appropriate option based on each patient's individual circumstances, imaging results, and response to therapy.
- Ranibizumab (Lucentis), approved in 2006, is typically given every four weeks
- Aflibercept (Eylea), approved in 2011, is administered every four to eight weeks after an initial loading period
- Faricimab (Vabysmo) targets both VEGF and a second pathway called Ang-2, with the possibility of dosing every four to sixteen weeks in eligible patients
- Brolucizumab (Beovu) can be given every eight to twelve weeks, though a risk of retinal vasculitis must be carefully considered in treatment planning
- Bevacizumab (Avastin) is widely used off-label for wet AMD and is typically given every four to six weeks; it is FDA-approved for cancer treatment but not for ocular conditions, though it has a long and well-studied track record in retinal care
Each of these medications has demonstrated effectiveness. The choice between them is made by the retina specialist based on the individual patient's needs, clinical picture, and treatment goals.
High-dose aflibercept, known as Eylea HD, was FDA-approved as the first injectable anti-VEGF therapy that allows dosing intervals of up to five months for wet AMD in appropriate patients. This extended schedule can meaningfully reduce the number of office visits and injections required per year, which is an important benefit for patients who find frequent appointments difficult. Treatment typically begins with monthly injections during a loading phase before intervals are gradually extended based on how the eye responds.
Most anti-VEGF treatment plans begin with a loading phase, typically three consecutive monthly injections, to quickly bring abnormal blood vessel activity under control. After this initial period, the retina specialist determines the best ongoing schedule for each patient. Common approaches include fixed monthly dosing, a treat-and-extend protocol (gradually lengthening the time between injections while the eye remains stable), or as-needed dosing guided by regular OCT imaging.
Timing is critical. Evidence strongly supports initiating treatment within days of a wet AMD diagnosis for the best possible visual outcomes. Delays allow abnormal vessels to cause additional, potentially irreversible damage to the macula. Any new symptoms of wet AMD should prompt contact with a retina specialist the same day or first thing the following morning.
What to Expect From Treatment
Understanding what the injection procedure involves and what realistic outcomes look like helps patients feel more prepared and stay committed to a treatment plan that may span many years.
Intravitreal injections are performed in the retina specialist's office. Anesthetic drops are applied to numb the eye, and the surface of the eye and surrounding area is cleaned with an antiseptic solution. The injection itself takes only a few seconds. Most patients describe feeling mild pressure rather than sharp pain. Afterward, some redness, a gritty sensation, or minor irritation may occur, but these effects typically resolve within a day or two. Most patients return to normal daily activities the same day.
After beginning treatment, regular follow-up visits are an essential part of care. At each visit, OCT imaging measures the amount of fluid remaining in the retina and assesses how well the treatment is working. Based on these results, the retina specialist may adjust the frequency of injections. Keeping every follow-up appointment consistently is critical. Skipping visits or stopping treatment prematurely can allow abnormal blood vessels to become active again and cause further vision loss.
Anti-VEGF treatment can stabilize vision in most patients and improve it in a meaningful number of people. However, outcomes vary from person to person and depend on factors such as how early treatment is started, how much damage occurred before diagnosis, and how the individual eye responds to medication. Some patients experience noticeable improvement in visual clarity. Others maintain their current level without further decline.
Wet AMD is a chronic condition, and most patients require ongoing treatment for years. While some may be able to extend the time between injections as their condition stabilizes, maintaining the recommended treatment schedule remains the most reliable way to protect as much central vision as possible over the long term.
Living With Wet AMD
Managing wet AMD well goes beyond injections and appointments. Practical lifestyle adjustments, emotional support, and attentive monitoring of both eyes all play important roles in day-to-day quality of life.
Many people with wet AMD benefit from low vision tools such as magnifying glasses, large-print books, adjustable lighting, and electronic devices with zoom or text enlargement features. An occupational therapist who specializes in low vision can help identify practical strategies for everyday tasks including cooking, reading, and managing medications. Small adjustments to your daily environment can help maintain independence and reduce frustration as vision changes occur.
Supporting your overall health also matters. Eating a diet rich in leafy green vegetables and fish, staying physically active, and avoiding smoking all contribute to retinal health. For patients with intermediate or advanced AMD, the AREDS2 vitamin formula (a specific combination of antioxidants and minerals studied in the Age-Related Eye Disease Study 2) may be recommended by a retina specialist to help slow further progression.
A diagnosis of wet AMD can feel frightening and overwhelming. It is completely normal to experience frustration, anxiety, or grief over changes to your vision. Connecting with others who understand this experience, through support groups in person or online, can provide both practical guidance and genuine encouragement. Organizations such as the Macular Degeneration Association and the BrightFocus Foundation offer educational resources and peer communities for people living with AMD.
If you have wet AMD in one eye, monitoring the other eye is especially important. Checking an Amsler grid daily with each eye separately is one of the most reliable ways to detect early changes at home. Report any new distortion, blank spots, or blurring in the second eye to your retina specialist immediately rather than waiting for a scheduled appointment. Because the risk of conversion in the fellow eye is substantially elevated, proactive monitoring is one of the most valuable steps you can take to protect your remaining vision.
When to See a Retina Specialist
Whether you are currently managing dry AMD or already receiving treatment for wet AMD, knowing when to schedule a visit and when to seek urgent care is an essential part of protecting your eyesight.
If you have been diagnosed with dry AMD, regular visits to a retina specialist form the foundation of your care. How often you need to be seen depends on the stage of your disease. People with early dry AMD may need annual exams, while those with intermediate or advanced dry AMD typically need visits every few months. Your retina specialist will recommend a monitoring schedule based on your specific findings, risk factors, and history.
Certain new or worsening symptoms may indicate that dry AMD has converted to wet, or that existing wet AMD has become more active. If any of the following occur, seek care the same day rather than waiting for a routine appointment.
- Straight lines suddenly appearing wavy, bent, or distorted
- New dark, gray, or blank spots appearing in the center of your vision
- A sudden, noticeable drop in visual sharpness in one eye
- A shadow, curtain, or veil appearing over part of your visual field
- Rapid worsening of vision that had previously been stable
Contact a retina specialist the same day these symptoms appear. If same-day access is not available, seek emergency eye care. With wet AMD, every day without treatment allows additional damage to occur in the macula.
For patients with geographic atrophy, the advanced form of dry AMD characterized by permanent loss of patches of retinal cells, newer treatment options have become available. Two complement inhibitor medications, pegcetacoplan (Syfovre) and avacincaptad pegol (Izervay), have been FDA-approved to help slow the progression of geographic atrophy. These treatments are distinct from anti-VEGF therapy and are not used for wet AMD. A retina specialist can evaluate whether either option may be appropriate for your individual situation.
Frequently Asked Questions
These questions address common concerns that arise after an AMD diagnosis or during ongoing treatment, and offer guidance on next steps.
There is currently no cure for wet AMD. However, anti-VEGF treatments are highly effective at blocking abnormal blood vessel growth and leakage, and many patients experience stabilized vision or meaningful partial improvement. Sustaining these results typically requires ongoing treatment over the long term. Research into gene therapy and sustained-delivery drug implants is active and may one day reduce the frequency of injections needed, but these approaches are not yet part of standard care.
The most common early signs are straight lines appearing wavy or distorted, new dark or blank spots in central vision, and a sudden change in visual sharpness. Using an Amsler grid daily with each eye is one of the most practical ways to detect these changes at home. If you notice anything out of the ordinary, call a retina specialist the same day rather than monitoring it yourself and hoping it resolves. The sooner treatment begins after conversion, the better the likely outcome for your vision.
The eye is numbed with anesthetic drops before every injection, so the large majority of patients describe feeling pressure rather than sharp pain during the procedure. Mild redness, a gritty feeling, or brief irritation may follow and typically resolve within a day or two. Many patients report that the experience is far less uncomfortable than they expected beforehand. Knowing that each injection is actively working to protect central vision helps most people stay committed to the treatment schedule over time.
Wet AMD is a long-term condition, and most patients require ongoing treatment to keep abnormal blood vessel activity suppressed. Some patients are able to extend the time between injections as their condition becomes more stable, and newer medications such as high-dose aflibercept and faricimab offer longer dosing intervals for eligible patients. Your retina specialist will review your imaging results at each visit to determine the right interval for you. Staying in treatment, even when vision feels unchanged, is what keeps the condition under control.
There is no guaranteed way to prevent dry AMD from becoming wet, but several steps may reduce your risk and support retinal health. Not smoking is among the most impactful choices you can make, as it directly affects blood vessel health throughout the eye. Eating a diet rich in leafy greens and fish, managing cardiovascular health, and staying physically active are all beneficial. If your retina specialist recommends the AREDS2 vitamin formula, taking it consistently may help slow progression of intermediate or advanced dry AMD. Above all, keeping every scheduled monitoring visit gives you the best chance of catching any conversion early, when treatment is most effective.
Yes, absolutely. Wet AMD can develop and cause measurable damage to the retina before any symptoms become noticeable. OCT imaging can detect fluid beneath the retina before it produces visible changes in your vision, which is exactly why regular imaging-based visits are so valuable. Feeling like nothing has changed is not a reliable indicator that conversion has not begun. Scheduled visits exist to catch changes before they become serious and harder to treat.
Expert Retina Care Across Connecticut
At New England Retina Associates, our fellowship-trained vitreoretinal surgeons provide specialized care for patients with AMD at every stage of the disease, across our four Connecticut locations. We offer same-day appointments for urgent symptoms and the full range of diagnostic imaging, monitoring, and treatment services needed to manage wet AMD with precision and continuity. If you have been referred by your eye doctor or are seeking care after noticing new changes in your vision, we are here and ready to help you protect what matters most.
30 Years of Care & Commitment
